Search results for " protocol"

showing 10 items of 1320 documents

Translation through Visualization

2005

There are many aspect of professional translation. Problem solving is certainly one of them, and visualization has occasionally been recommended in this context. In this article, think aloud protocols (dialogue protocols) are analysed with the aim of observing instances of visualizations that lead to successful translations. As a heuristic means cognitive notions (prototypes, scenes and frames and focus) are used. In general, it seems that visualizing details of a scene helps translators to arrive at creative translations.

Linguistics and LanguageFocus (computing)Social Sciences and HumanitiesComputer scienceHeuristicContext (language use)CognitionTranslation (geometry)TAP studiesLanguage and LinguisticsLinguisticsVisualizationproblem solvingHuman–computer interactionSciences Humaines et SocialesThink aloud protocolcreativityvisualizationcognitive processes
researchProduct

A Multi-Phase Decode-and-Forward Transmission Protocol in Cognitive Relay Networks: Outage Analysis and Relay Power Allocation

2015

Consider an underlay cognitive relay network with multiple source and destination pairs and that a decode-and-forward scheme is adopted at the relay. We propose a multi-phase transmission protocol in this paper which involves cooperation among source, relay and destination nodes. Given perfect interference elimination before decoding at the destination nodes, we derive closed-form expressions for outage probability calculation over Rayleigh fading channels. Furthermore, the optimal relay power allocation factor which leads to minimal outage probability is determined. Numerical results reveal the conditions under which satisfactory performance can be achieved based on the proposed scheme.

Link Access Procedure for Frame Relaybusiness.industryComputer scienceComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSData_CODINGANDINFORMATIONTHEORYlaw.inventionPower (physics)RelaylawComputer Science::Networking and Internet ArchitectureUnderlayTransmission protocolbusinessDecoding methodsRelay channelComputer Science::Information TheoryCommunication channelRayleigh fadingComputer network2015 IEEE 81st Vehicular Technology Conference (VTC Spring)
researchProduct

Is TCP Packet Reordering Always Harmful?

2004

IP networks do not provide any guarantee that packets belonging to the same flow are delivered in the correct order. Out-of-order reception of packets was commonly considered due to pathological network conditions (such as link failures, etc.). However, it has been shown that packet reordering is a phenomenon which occurs even in normal network operation, due to a number of link-level and/or router-level implementation features, such as local parallelism and load balancing. Packet reordering is intuitively considered as a negative phenomenon, which may severely affect TCP traffic performance since it is expected to cause inefficient usage of the available link bandwidth and is expected to i…

Link state packetNetwork packetbusiness.industryComputer scienceTransmission Control ProtocolRadio Link ProtocolDistributed computingComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSEnd-to-end delayLoad balancing (computing)law.inventionTCP global synchronizationlawNetwork performancebusinessComputer network
researchProduct

Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study.

2008

Abstract Background Neoplastic seeding of hepatocellular carcinoma may arise after radiofrequency ablation. Aims In order to clarify the real risk of seeding, we observed a prospective cohort of patients undergoing radiofrequency ablation. Methods Ninety-three (22.9%) out of 406 consecutive patients with hepatocellular carcinoma superimposed to cirrhosis diagnosed at our Liver Unit (2000–2005) were selected for radiofrequency ablation according to the Barcelona 2000 EASL guidelines. Seventy-one patients were treated by a percutaneous approach and 22 at laparotomy. After radiofrequency ablation ultrasound scan was repeated every 3 months and spiral-computed tomography every 6 months. Results…

Liver CirrhosisMalemedicine.medical_specialtyNeoplastic SeedingCirrhosisCarcinoma HepatocellularRadiofrequency ablationmedicine.medical_treatmentlaw.inventionNeoplasm SeedingClinical ProtocolslawLaparotomyMedicineHumansIn patientProspective StudiesProspective cohort studyAgedHepatologybusiness.industryLiver NeoplasmsGastroenterologyMiddle Agedmedicine.diseaseTreatment OutcomeHepatocellular carcinomaCatheter AblationSeedingFemaleRadiologybusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Multisciplinary management of patients with liver metastasis from colorectal cancer

2016

Abstract: Colorectal cancer (CRC) is one of the leading causes of cancer-related death. Surgery, radiotherapy and chemotherapy have been till now the main therapeutic strategies for disease control and improvement of the overall survival. Twenty-five per cent (25%) of CRC patients have clinically detectable liver metastases at the initial diagnosis and approximately 50% develop liver metastases during their disease course. Twenty-thirty per cent (20%-30%) are CRC patients with metastases confined to the liver. Some years ago various studies showed a curative potential for liver metastases resection. For this reason some authors proposed the conversion of unresectable liver metastases to res…

Liver metastase0301 basic medicinemedicine.medical_specialtyChemotherapy; Colorectal cancer; Liver metastases; Liver resection; Multidisciplinary team; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Disease Management; Hepatectomy; Humans; Liver Neoplasms; Receptor; Epidermal Growth Factor; GastroenterologyColorectal cancermedicine.medical_treatmentAngiogenesis InhibitorsColorectal NeoplasmReviewChemotherapy; Colorectal cancer; Liver metastases; Liver resection; Multidisciplinary team; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Disease Management; Hepatectomy; Humans; Liver Neoplasms; Receptor Epidermal Growth Factor; GastroenterologyMetastasis03 medical and health sciencesLiver metastases0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCombined Modality TherapyChemotherapyHepatectomyHumansDisease management (health)ChemotherapyAntineoplastic Combined Chemotherapy ProtocolLiver resectionEpidermal Growth Factorbusiness.industryGeneral surgeryHepatobiliary diseaseLiver NeoplasmsGastroenterologyDisease ManagementGeneral MedicineMultidisciplinary teammedicine.diseaseColorectal cancerCombined Modality TherapyRadiation therapyErbB Receptors030104 developmental biologyLiver Neoplasm030220 oncology & carcinogenesisReceptor Epidermal Growth FactorHuman medicineHepatectomybusinessColorectal NeoplasmsAngiogenesis InhibitorHumanReceptor
researchProduct

A Coexistence Analysis of Blockchain, SCADA Systems, and OpenADR for Energy Services Provision

2022

The advent of blockchain technology allows the raise of new business models for the electricity market, opening the way also to end-users and letting them offer regulation services to the power grid. Thanks to the characteristic of being distributed, the blockchain technology could be a solution to balancing problems caused by the penetration of renewable sources, implementing a platform for Demand-Response programs delivery. Demand-Response allows consumers to respond to market signals by increasing or reducing their energy consumption, contributing to greater flexibility and stability of the grid and to a more efficient use of infrastructures and energy resources. Currently, Demand-Respon…

Load managementGeneral Computer ScienceOpenADRInternet of ThingsGeneral EngineeringSmart gridsSCADA systemscommunication protocolBlockchainsPower systemsDistributed power generationBlockchainSecurityindustrial applicationsGeneral Materials ScienceSCADAElectrical and Electronic Engineeringdistributed energy servicesProtocols
researchProduct

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

2010

The adenocarcinoma of the lung has recently shown peculiar molecular characteristics, which relate with both carcinogenesis and response to targeted drugs. Several molecular alterations have been defined as "driver mutations". These are responsible for both the initiation and maintenance of the malignancy. The epidermal growth factor receptor (EGFR) pathway is the main regulator of cell function and cancer development. It has a widely defined role in the occurrence of driver mutations. Up till now EGFR gene mutations, KRAS gene mutations and EML4-ALK fusion genes are the most widely recognized alterations involved in both the biology and the clinical management of lung adenocarcinoma. In th…

Lung NeoplasmsOncogene Proteins FusionSettore MED/06 - Oncologia MedicaEGFRGene ExpressionAdenocarcinomaGene mutationmedicine.disease_causeProto-Oncogene Proteins p21(ras)Phosphatidylinositol 3-KinasesPredictive Value of TestsProto-Oncogene ProteinsAntineoplastic Combined Chemotherapy ProtocolsmedicineAdenocarcinoma of the lungHumansRadiology Nuclear Medicine and imagingMolecular Targeted TherapyEpidermal growth factor receptorTyrosine kinase inhibitorsMutationbiologybusiness.industryDriver mutationGeneral MedicineProtein-Tyrosine KinasesPrognosismedicine.diseaseErbB ReceptorsTreatment OutcomeOncologyMutationImmunologyras ProteinsCancer researchbiology.proteinAdenocarcinomaKRASCarcinogenesisbusinessTyrosine kinaseAlgorithmsCancer Treatment Reviews
researchProduct

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

2014

Abstract: Introduction: Treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) yields tumour responses in non-small cell lung cancer (NSCLC) patients harbouring activating EGFR mutations. However, even in long-lasting responses, resistance to EGFR TKIs invariably occurs. Areas covered: This review examines resistance mechanisms to EGFR TKI treatment, which mainly arise from secondary EGFR mutations. Other resistance-inducing processes include mesenchymal-epithelial transition factor (MET) amplification, epithelial-mesenchymal transformation, phenotypic change from NSCLC to small-cell lung carcinoma, and modifications in parallel signalling pathways. Current…

Lung NeoplasmsSettore MED/06 - Oncologia MedicaAfatinibNovel therapeutic strategiesLapatinibmedicine.disease_causeNSCLCT790Mchemistry.chemical_compoundErbB ReceptorsCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineAnimalsHumansRadiology Nuclear Medicine and imagingEpidermal growth factor receptorProtein Kinase InhibitorsEGFR inhibitorsbiologybusiness.industryEGFR mutations; TKI inhibitors resistance; NSCLC; New drugs; Novel therapeutic strategiesGeneral MedicineNew drugEGFR mutationsCombined Modality TherapyDacomitinibrespiratory tract diseasesErbB ReceptorsNew drugsOncologychemistryDrug Resistance NeoplasmCancer researchbiology.proteinKRASHuman medicineEGFR mutationbusinessmedicine.drugTKI inhibitors resistanceCancer Treatment Reviews
researchProduct

Non-linear protocols for optimal distributed consensus in networks of dynamic agents

2006

We consider stationary consensus protocols for networks of dynamic agents with fixed topologies. At each time instant, each agent knows only its and its neighbors'' state, but must reach consensus on a group decision value that is function of all the agents'' initial state. We show that the agents can reach consensus if the value of such a function is time-invariant when computed over the agents'' state trajectories. We use this basic result to introduce a non-linear protocol design rule allowing consensus on a quite general set of values. Such a set includes, e.g., any generalized mean of order p of the agents'' initial states. As a second contribution we show that our protocol design is t…

Lyapunov functionMathematical optimizationDecentralized controlGeneral Computer ScienceConsensus protocols; Decentralized control; Networks; Optimal controlUniform consensussymbols.namesakeConsensusComputer Science::Systems and ControlElectrical and Electronic EngineeringMathematicsMechanism designSupervisorbusiness.industryMechanical EngineeringRational agentDecentralised systemOptimal controlComputer Science::Multiagent SystemsConsensus protocolsControl and Systems EngineeringsymbolsArtificial intelligenceSettore MAT/09 - Ricerca OperativaNetworksbusinessGame theorySystems & Control Letters
researchProduct

Emerging MEK inhibitors

2010

IMPORTANCE OF THE FIELD: The Ras/Raf/MEK/ERK pathway is often activated by genetic alterations in upstream signaling molecules. Integral components of this pathway such as Ras and B-Raf are also activated by mutation. The Ras/Raf/MEK/ERK pathway has profound effects on proliferative, apoptotic and differentiation pathways. This pathway can often be effectively silenced by MEK inhibitors. AREAS COVERED BY THIS REVIEW: This review will discuss targeting of MEK which could lead to novel methods to control abnormal proliferation which arises in cancer and other proliferative diseases. This review will cover the scientific literature from 1980 to present and is a follow on from a review which fo…

MAPK/ERK pathwayCell signalingAntineoplastic Agentsmedicine.disease_causemekerkEnzyme activatorNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineAnimalsHumansPharmacology (medical)Protein phosphorylationProtein Kinase InhibitorsMEK inhibitorsCell ProliferationCancerPharmacologyapoptosis; cancer; erk; kinases; mek; mek inhibitors; proliferative disorders; protein phosphorylation; signal transductionproliferative disordersMutationKinasebusiness.industryapoptosisApoptosiCancerDrugs InvestigationalMAP Kinase Kinase Kinasesmedicine.diseaseprotein phosphorylationCell biologyEnzyme ActivationTreatment OutcomekinasesChemotherapy AdjuvantRadiotherapy AdjuvantSignal transductionbusinesssignal transductionExpert Opinion on Emerging Drugs
researchProduct